ARTA
FBIO icon

A.R.T. Advisors’s Fortress Biotech FBIO Stock Holding History

A.R.T. Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,566
Closed -$99K – 366
2019
Q4 		$99K Sell
2,566
-1,539
-37% -$39.5K ﹤0.01% 1214
2019
Q3 		$87K Buy
4,105
+1,597
+64% +$37.6K ﹤0.01% 1273
2019
Q2 		$56K Buy
+2,508
New +$64.5K ﹤0.01% 1241
2019
Q1 		– Sell
-822
Closed -$11K – 1397
2018
Q4 		$11K Sell
822
-842
-51% -$14.1K ﹤0.01% 1264
2018
Q3 		$39K Buy
1,664
+25
+2% +$800 ﹤0.01% 1327
2018
Q2 		$73K Buy
1,639
+672
+69% +$37.8K ﹤0.01% 1315
2018
Q1 		$65K Sell
967
-760
-44% -$48.1K ﹤0.01% 1388
2017
Q4 		$103K Buy
+1,727
New +$102K ﹤0.01% 1251
2013
Q4 		– Sell
-6,933
Closed -$729K – 1331
2013
Q3 		$729K Buy
+6,933
New +$850K 0.04% 621

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

A.R.T. Advisors's FBIO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Fortress Biotech (FBIO) in Q1 2020, closing a stake of 2,566 shares — an estimated $99K sold.

A.R.T. Advisors first reported a position in FBIO in Q3 2013 and held it in 9 quarters. The position peaked at $729K in Q3 2013. 55 funds tracked by Wall St. Rank hold FBIO as of Q1 2020.

  • A.R.T. Advisors reported no remaining Fortress Biotech position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 2,566 Fortress Biotech shares in Q1 2020, an estimated $99K.
  • A.R.T. Advisors first reported a position in Fortress Biotech in Q3 2013 and held it in 9 quarters.
  • A.R.T. Advisors's Fortress Biotech position peaked at $729K in Q3 2013.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.